NXGL
NEXGEL, Inc.
NASDAQ · USHealthcareMedical - Instruments & Supplies
$0.45-5.49%
Price as of Jul 20, 2026
NXGL growth
NEXGEL, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +10.1%
- EBITDA
- +14.2%
- EBIT
- -2.1%
- EPS
- +14.3%
- Free cash flow
- +58.9%
- Operating cash flow
- +55.4%
Forward estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +77.3%
- EBITDA
- +27.0%
- EBIT
- +5.7%
- Net income
- +8.6%
- EPS
- +24.0%
- Free cash flow
- +68.0%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.